Ozden Ilgin, Tekant Yaman, Bilge Orhan, Acarli Koray, Alper Aydin, Emre Ali, Rozanes Izzet, Ozsut Halit, Ariogul Orhan
Department of General Surgery, Hepatopancreatobiliary Surgery Unit, Istanbul University, Istanbul, Turkey.
Am J Surg. 2005 Jun;189(6):702-6. doi: 10.1016/j.amjsurg.2005.03.010.
Iatrogenic factors became the leading mechanisms of severe cholangitis in a referral center.
The records of the 58 patients treated for severe cholangitis between 1996 and May 2004 (inclusive) were evaluated.
The most frequent underlying diseases were periampullary tumors and mid-bile duct carcinomas (22), followed by proximal cholangiocarcinomas (14). The triggering mechanism was an incomplete endoscopic retrograde cholangiopancreatography (ERCP) in 32 patients, incomplete or inappropriate percutaneous transhepatic biliary drainage (PTBD) in 6, apparently successful ERCP and stenting in 1, and percutaneous transhepatic cholangiography in 1. PTBD was the treatment of choice (38). Mortality was 29% (17/58); the major causes were refractory sepsis (8) and incomplete biliary drainage (advanced tumor, technical failure, or hemobilia) (8).
In this series composed predominantly of patients referred after development of sepsis, ERCP and PTBD complications were the leading mechanisms of severe cholangitis. Nonoperative biliary manipulations are invasive procedures with potentially fatal complications. The decisions to perform such procedures and periprocedural management are responsibilities of an experienced multidisciplinary team.
在一家转诊中心,医源性因素成为严重胆管炎的主要发病机制。
对1996年至2004年5月(含)期间接受严重胆管炎治疗的58例患者的病历进行评估。
最常见的基础疾病是壶腹周围肿瘤和胆管中段癌(22例),其次是近端胆管癌(14例)。触发机制为32例患者内镜逆行胰胆管造影术(ERCP)操作不完全,6例经皮经肝胆道引流术(PTBD)不完全或不恰当,1例ERCP和支架置入术看似成功,1例经皮经肝胆管造影术。PTBD是首选治疗方法(38例)。死亡率为29%(17/58);主要原因是难治性脓毒症(8例)和胆管引流不完全(晚期肿瘤、技术失败或胆道出血)(8例)。
在这个主要由脓毒症发生后转诊的患者组成的系列研究中,ERCP和PTBD并发症是严重胆管炎的主要发病机制。非手术胆道操作是具有潜在致命并发症的侵入性操作。决定进行此类操作及围手术期管理是经验丰富的多学科团队的职责。